Imageens

Imageens is a medical technology company based in Paris, founded in 2017. The company specializes in AI-enabled medical image analysis software, focusing on cardiovascular health. Its mission is to enhance cardiovascular prevention and care by utilizing advanced technology to derive precise medical insights from cardiovascular MRI data. The flagship product, ArtFun+, is a clinically validated AI software that measures MRI-based predictive biomarkers related to arterial stiffness, a significant risk factor for cardiovascular diseases. ArtFun+ aids in the early detection of vascular aging and cardiovascular disease risk, providing vascular surgeons and cardiologists with individualized risk stratification to inform treatment decisions. This is particularly beneficial for managing conditions like severe asymptomatic carotid stenosis, where accurate risk assessment is crucial. Imageens combines AI with biomechanical modeling to analyze cardiovascular MRI data, helping healthcare providers predict stroke risk and optimize patient management. The company aims to improve cardiovascular outcomes through precision medicine and advanced imaging analytics, addressing the needs of healthcare providers managing cardiovascular diseases.

• Employees 4
• Founded 2017
• Annual Revenue $1000000
• Total Funding $2118129